ALKEM

Alkem Laboratories Share Price

₹5,105.50 -10.5 (-0.21%)

02 May, 2025 11:01

SIP TrendupStart SIP in ALKEM

Start SIP

Performance

  • Low
  • ₹5,053
  • High
  • ₹5,140
  • 52 Week Low
  • ₹4,407
  • 52 Week High
  • ₹6,440
  • Open Price₹5,120
  • Previous Close₹5,116
  • Volume14,177

Investment Returns

  • Over 1 Month + 5.58%
  • Over 3 Month + 1.51%
  • Over 6 Month -12.05%
  • Over 1 Year + 5.64%
SIP Lightning

Smart Investing Starts Here Start SIP with Alkem Laboratories for Steady Growth!

Invest Now

Alkem Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 28.4
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 61,044
  • P/B Ratio
  • 5.3
  • Average True Range
  • 131.75
  • EPS
  • 180.89
  • Dividend Yield
  • 0.8
  • MACD Signal
  • 51.06
  • RSI
  • 58.99
  • MFI
  • 80.06

Alkem Laboratories Financials

Alkem Laboratories Technicals

EMA & SMA

Current Price
₹5,105.50
-10.5 (-0.21%)
pointer
  • stock-down_img
  • Bearish Moving Average 3
  • stock-up_img
  • Bullish Moving Average 13
  • 20 Day
  • ₹4,990.64
  • 50 Day
  • ₹4,962.13
  • 100 Day
  • ₹5,077.26
  • 200 Day
  • ₹5,166.26

Resistance and Support

5107.63 Pivot Speed
  • R3 5,299.17
  • R2 5,232.53
  • R1 5,174.27
  • S1 5,049.37
  • S2 4,982.73
  • S3 4,924.47

What's your outlook on Alkem Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Alkem Laboratories Ltd, is one of India’s largest pharmaceutical companies, known for its leading brands like Clavam and Pan-D. With 21 manufacturing facilities and global presence in over 50 countries, Alkem drives innovation with 500+ scientists across 5 R&D centers.

Alkem Laboratories has an operating revenue of Rs. 12,756.59 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 16% is great, ROE of 17% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and around 5% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 20% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 53 which is a POOR score indicating inconsistency in earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Alkem Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-07 Quarterly Results & Interim Dividend
2024-11-13 Quarterly Results
2024-08-09 Quarterly Results
2024-05-29 Audited Results & Final Dividend
2024-02-09 Quarterly Results & Interim Dividend
Date Purpose Remarks
2025-02-14 INTERIM Rs.37.00 per share(1850%)Interim Dividend
2024-08-10 FINAL Rs.5.00 per share(250%)Final Dividend
2024-02-17 INTERIM Rs.35.00 per share(1750%)Interim Dividend
2023-08-10 FINAL Rs.10.00 per share(500%)Final Dividend
2023-02-18 INTERIM Rs.15.00 per share(750%)Interim Dividend
View More

Alkem Laboratories F&O

Alkem Laboratories Shareholding Pattern

55.13%
14.97%
3.2%
9.4%
0%
15.77%
1.53%

About Alkem Laboratories

  • NSE Symbol
  • ALKEM
  • BSE Symbol
  • 539523
  • Managing Director
  • Mr. Sandeep Singh
  • ISIN
  • INE540L01014

Similar Stocks to Alkem Laboratories

Alkem Laboratories FAQs

Alkem Laboratories share price is ₹5,105 As on 02 May, 2025 | 10:47

The Market Cap of Alkem Laboratories is ₹61043.9 Cr As on 02 May, 2025 | 10:47

The P/E ratio of Alkem Laboratories is 28.4 As on 02 May, 2025 | 10:47

The PB ratio of Alkem Laboratories is 5.3 As on 02 May, 2025 | 10:47

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23